8TCR

Structure of glucose bound Alistipes sp. 3-Keto-beta-glucopyranoside-1,2-Lyase AL1


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.08 Å
  • R-Value Free: 0.229 
  • R-Value Work: 0.182 
  • R-Value Observed: 0.184 

Starting Model: in silico
View more details

wwPDB Validation   3D Report Full Report


Ligand Structure Quality Assessment 


This is version 1.2 of the entry. See complete history


Literature

An alternative broad-specificity pathway for glycan breakdown in bacteria.

Nasseri, S.A.Lazarski, A.C.Lemmer, I.L.Zhang, C.Y.Brencher, E.Chen, H.M.Sim, L.Panwar, D.Betschart, L.Worrall, L.J.Brumer, H.Strynadka, N.C.J.Withers, S.G.

(2024) Nature 631: 199-206

  • DOI: https://doi.org/10.1038/s41586-024-07574-y
  • Primary Citation of Related Structures:  
    8TCD, 8TCR, 8TCS, 8TCT, 8TDA, 8TDE, 8TDF, 8TDH, 8TDI

  • PubMed Abstract: 

    The vast majority of glycosidases characterized to date follow one of the variations of the 'Koshland' mechanisms 1 to hydrolyse glycosidic bonds through substitution reactions. Here we describe a large-scale screen of a human gut microbiome metagenomic library using an assay that selectively identifies non-Koshland glycosidase activities 2 . Using this, we identify a cluster of enzymes with extremely broad substrate specificities and thoroughly characterize these, mechanistically and structurally. These enzymes not only break glycosidic linkages of both α and β stereochemistry and multiple connectivities, but also cleave substrates that are not hydrolysed by standard glycosidases. These include thioglycosides, such as the glucosinolates from plants, and pseudoglycosidic bonds of pharmaceuticals such as acarbose. This is achieved through a distinct mechanism of hydrolysis that involves oxidation/reduction and elimination/hydration steps, each catalysed by enzyme modules that are in many cases interchangeable between organisms and substrate classes. Homologues of these enzymes occur in both Gram-positive and Gram-negative bacteria associated with the gut microbiome and other body parts, as well as other environments, such as soil and sea. Such alternative step-wise mechanisms appear to constitute largely unrecognized but abundant pathways for glycan degradation as part of the metabolism of carbohydrates in bacteria.


  • Organizational Affiliation

    Department of Chemistry, University of British Columbia, Vancouver, British Columbia, Canada.


Macromolecules
Find similar proteins by:  (by identity cutoff)  |  3D Structure
Entity ID: 1
MoleculeChains Sequence LengthOrganismDetailsImage
Sugar phosphate isomeraseA [auth C],
B,
C [auth A],
D
286AlistipesMutation(s): 0 
Gene Names: A5CPYCFAH4_05830
UniProt
Find proteins for A0A9P3ZKE6 (Alistipes onderdonkii)
Explore A0A9P3ZKE6 
Go to UniProtKB:  A0A9P3ZKE6
Entity Groups  
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupA0A9P3ZKE6
Sequence Annotations
Expand
  • Reference Sequence
Small Molecules
Ligands 3 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
GLC (Subject of Investigation/LOI)
Query on GLC

Download Ideal Coordinates CCD File 
F [auth C]
G [auth C]
J [auth B]
K [auth B]
L [auth B]
F [auth C],
G [auth C],
J [auth B],
K [auth B],
L [auth B],
N [auth A],
O [auth A],
Q [auth D],
R [auth D],
S [auth D]
alpha-D-glucopyranose
C6 H12 O6
WQZGKKKJIJFFOK-DVKNGEFBSA-N
MLI
Query on MLI

Download Ideal Coordinates CCD File 
E [auth C]MALONATE ION
C3 H2 O4
OFOBLEOULBTSOW-UHFFFAOYSA-L
CO
Query on CO

Download Ideal Coordinates CCD File 
H [auth C],
I [auth B],
M [auth A],
P [auth D]
COBALT (II) ION
Co
XLJKHNWPARRRJB-UHFFFAOYSA-N
Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 2.08 Å
  • R-Value Free: 0.229 
  • R-Value Work: 0.182 
  • R-Value Observed: 0.184 
  • Space Group: P 21 21 21
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 47.517α = 90
b = 113.679β = 90
c = 208.58γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
XDSdata reduction
Aimlessdata scaling
PHASERphasing

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History & Funding Information

Deposition Data


Funding OrganizationLocationGrant Number
Canadian Institutes of Health Research (CIHR)Canada--

Revision History  (Full details and data files)

  • Version 1.0: 2024-06-12
    Type: Initial release
  • Version 1.1: 2024-07-03
    Changes: Database references
  • Version 1.2: 2024-07-17
    Changes: Database references